U.S. markets closed
  • S&P Futures

    +2.75 (+0.08%)
  • Dow Futures

    +101.00 (+0.37%)
  • Nasdaq Futures

    -28.25 (-0.25%)
  • Russell 2000 Futures

    +1.50 (+0.10%)
  • Crude Oil

    -0.05 (-0.13%)
  • Gold

    +1.70 (+0.09%)
  • Silver

    +0.06 (+0.25%)

    -0.0001 (-0.01%)
  • 10-Yr Bond

    -0.0070 (-1.04%)
  • Vix

    -0.92 (-3.31%)

    +0.0008 (+0.06%)

    +0.1160 (+0.11%)

    -3.58 (-0.03%)
  • CMC Crypto 200

    +1.28 (+0.60%)
  • FTSE 100

    +25.17 (+0.43%)
  • Nikkei 225

    +40.90 (+0.18%)

3 Stocks To Watch As Healthcare Market Evolves

CORAL GABLES, FL / ACCESSWIRE / November 5, 2018 / Healthcare companies are taking a new and novel approach the health tech in the form of new innovation that takes the guesswork out of tracking health & reporting results. Furthermore, new digital screening technology is allowing both patients and physicians to better understand many different health issues, more clearly. Roughly 10,000 boomers retire every day. The youngest, born in 1964, won't turn 65 until 2029. Considering the inevitable medical issues that come with old age, companies in this sector could potentially be looking at decades of strong demand.

Things like Wireless Healthcare are highly ambitious with the presence of various players with current and future market outlook in the developed and emerging markets. According to information from Market Reports World*, the global wireless healthcare market is expected to witness a compounded annual growth rate of 27.30 % during the forecast period of 2018-2023. The market is growing at a fast pace with the rise in growth, the growing number of Wireless Healthcare procedures, competition, and M&A activities. Today we're taking a closer look at Premier Health Group, Inc. (PHGRF)(PHGI.CN), Titan Pharmaceuticals (TTNP) and Rite Aid Corporation (RAD).

Premier Health Group, Inc. (PHGRF)(PHGI.CN) announced this morning that as a part of its expansion plans it will enter the Pharmacy market via acquisition and/or launching a new Canada based pharmacy in H1-2019. With Premier's acquisition of HealthVue Medical Clinics in August, this could be the next phase of growth for the company. Premier Health Group, Inc. ( PHGRF )(PHGI.CN) entered the primary care clinic and healthcare technology business via the HealthVue transaction and obtained access to a group of four Greater Vancouver-based fully integrated, paperless and electronic-medical-record-based medical clinics with a 10-year history, 22 healthcare professionals and over 100,000 active patients.

In the U.S. market, alone, the Telehealth industry is on fire right now, predicted to reach a $2.8 billion valuation by 2025, with the heat only intensifying with time. According to Reuters, the deployment of telemedicine has significantly altered the healthcare paradigm, due to the many technological advancements in the field of medical devices and services. With the growth that the mobile health segment is expecting, this news comes well timed.

Premier Health Group, Inc. ( PHGRF )(PHGI.CN) is actively reviewing a pipeline of additional pharmacy partners, which include bricks and mortar locations for acquisition and strategic new retail opportunities for pharmacies. "It is our position that the emergence of technology such as the ability for patients to electronically send their prescription(s) to a pharmacy for fulfillment and pick up at a later time or delivery directly to them at home or work will result in increased patient and consumer enrollment in apps that offer this type of functionality," added Dr.Hamza. Furthermore, the Company expects to provide additional updates on acquisitions in Q4-18 and Q1-19.

For More Information On Premier Health Group, Click Here

Titan Pharmaceuticals (TTNP) has seen a higher trading volume over the last week. ProNeura™, Titan's innovative drug delivery platform, is advancing the treatment of select chronic diseases by delivering low-dose, non-fluctuating medication levels for up to one year following a single procedure.

Titan Pharmaceuticals develops proprietary therapeutics for the treatment of select chronic diseases. The company's lead product is Probuphine, a six-month buprenorphine implant for the maintenance treatment of opioid addiction. The U.S. Food and Drug Administration approved Probuphine on May 26, 2016. Probuphine is the first marketed product to provide maintenance treatment of opioid addiction continuously for six months, according to the company.

Last month, Knight Therapeutics Inc. (GUD) announced the commercial availability of PROBUPHINE™ (buprenorphine hydrochloride subdermal implant), for the management of opioid dependence in patients clinically stabilized on no more than 8 mg of sublingual buprenorphine in combination with counseling and psychosocial support. Knight has the exclusive right to distribute PROBUPHINE in Canada under a license agreement with Titan Pharmaceuticals, Inc.

Shares of Titan reached early highs of $0.44 on Monday morning

For More Information On Titan, Click Here

Rite Aid Corporation (RAD) announced the preliminary results of stockholder voting that took place during the Company's 2018 Annual Meeting of Stockholders earlier today. As previously announced, Bruce G. Bodaken was appointed Chairman effective as of the meeting. Mr. Bodaken assumes this role from John T. Standley who will remain Chief Executive Officer and a member of the Board.

Rite Aid is one of the nation's leading drugstore chains with fiscal 2018 annual revenues of $21.5 billion. The company also owns EnvisionRxOptions, a multi-faceted healthcare and pharmacy benefit management (PBM) company supporting a membership base of more than 22 million members

Further to the expansion that mobile health could see in the future, Rite Aid is also taking a step in the same direction. More than 4,000 Rite Aid pharmacies nationwide now make it available for customers to access a suite of connected health and safety products and services via GreatCall. By providing an easier and more convenient method of managing health needs, GreatCall and other mHealth tech companies are bringing older adults into the mobile health market, which benefits the health care system and also provides this population of people with much-needed support.

For More Information On RiteAid, Click Here

What Is Stock Price (StockPrice.com)?

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.

StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2018 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for & were paid "500,000" shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6)Six month restriction is complete on 4/1/2019 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.

Contact Information:


SOURCE: StockPrice.com